Sclerostin, a protein that regulates bone formation and breakdown, is controlled by at least seven major factors including age, sex, exercise, kidney function, hormones, vitamin D, and metabolic disorders. According to Gram Research analysis, sclerostin levels show an inverse relationship with parathyroid hormone, meaning when one goes up, the other goes down. While blood sclerostin levels may eventually help doctors assess bone health, current research shows the measurement is too complex and influenced by too many factors to use as a standalone clinical tool without standardized testing methods
Your bones are constantly changing, and a protein called sclerostin acts like a master control switch for this process. According to Gram Research analysis, sclerostin levels in your blood are influenced by many factors including age, sex, exercise, kidney function, and hormones. A new review published in Growth Factors examines how sclerostin works and why measuring it might help doctors understand bone health better. However, scientists caution that sclerostin levels are complicated and affected by so many different things that doctors need to be careful when interpreting what the numbers mean for individual patients.
Key Statistics
A 2026 review in Growth Factors identified seven major physiological and pathological factors that influence sclerostin expression and circulating levels: age, gender, mechanical loading, renal function, hormonal changes, vitamin D status, and metabolic disorders.
Research shows sclerostin levels demonstrate a negative correlation with circulating parathyroid hormone levels, meaning sclerostin decreases when parathyroid hormone increases, indicating these two regulators work as opposing forces in bone metabolism.
The 2026 review notes that although serum sclerostin levels associate with bone mineral density, the clinical significance of changes in sclerostin levels must be interpreted carefully due to diverse influencing factors and lack of assay standardization across laboratories.
Sclerostin mediates the anabolic, or bone-building, effects of parathyroid hormone, suggesting that sclerostin reduction is necessary for parathyroid hormone to effectively stimulate new bone formation.
The Quick Take
- What they studied: How a bone-regulating protein called sclerostin is controlled by different body factors and whether measuring it in blood can help doctors assess bone health
- Who participated: This was a review article that analyzed existing research rather than conducting a new study with participants
- Key finding: Sclerostin levels are influenced by at least seven major factors: age, biological sex, physical activity, kidney function, hormones, vitamin D, and metabolic disorders. No single factor tells the whole story
- What it means for you: Blood tests measuring sclerostin might eventually help doctors predict bone problems, but they cannot rely on this measurement alone because too many things affect the levels. More standardized testing methods are needed before this becomes a routine clinical tool
The Research Details
This was a review article, meaning researchers examined and summarized all the existing scientific studies about sclerostin rather than conducting their own experiment. The authors looked at how sclerostin works in the body, what factors change its levels, how scientists measure it, and whether it could be useful as a clinical marker for bone health. They organized information about sclerostin’s role in bone formation and breakdown, its connection to other bone-regulating hormones, and the challenges in interpreting sclerostin measurements. This type of research is valuable because it brings together scattered findings from many studies to create a comprehensive picture of what we know and what we still need to learn.
Review articles are important because they help scientists and doctors understand the current state of knowledge on a topic. By examining all available research on sclerostin, this review identifies patterns, contradictions, and gaps in our understanding. This approach is especially useful for complex topics like sclerostin, where many different factors influence the results and different studies may reach different conclusions. The review helps establish what we know for certain versus what remains uncertain or controversial
As a review article in a peer-reviewed journal, this work was evaluated by other experts before publication. The strength of this review depends on how thoroughly the authors searched for studies and how carefully they evaluated the quality of the research they found. Review articles are generally considered reliable sources of information but are not as definitive as large, well-designed experiments. The authors appropriately note areas of controversy and uncertainty, such as vitamin D’s effects on sclerostin, which shows scientific honesty about the limits of current knowledge
What the Results Show
Sclerostin is a protein that acts as a brake on bone formation. It works by slowing down osteoblasts, the cells that build bone, while also affecting osteoclasts, the cells that break down bone. The amount of sclerostin in your blood changes based on multiple factors working together. Age affects sclerostin levels, with changes occurring as people get older. Biological sex influences sclerostin, meaning men and women may have different levels. Physical activity and mechanical loading (stress on bones from exercise or weight-bearing) significantly reduce sclerostin levels, which makes sense because active people need less of this bone-building brake. Kidney function matters because the kidneys help regulate sclerostin in the bloodstream. Hormonal changes, particularly those involving parathyroid hormone, show a clear relationship with sclerostin: when parathyroid hormone goes up, sclerostin goes down, and vice versa. This inverse relationship suggests these two regulators work as opposing forces to maintain bone balance.
Sclerostin also plays a role in how parathyroid hormone builds bone. When parathyroid hormone is present, it works partly by reducing sclerostin levels, allowing more bone formation to occur. Metabolic disorders, such as diabetes and obesity, can alter sclerostin levels in ways that may affect bone health. The relationship between vitamin D and sclerostin remains controversial, with different studies reaching different conclusions. Some research suggests vitamin D influences sclerostin, while other studies find no clear connection. Sclerostin levels do show some association with bone mineral density, the measure of how dense and strong bones are, suggesting it may reflect overall bone metabolism to some degree. However, this relationship is not strong enough to use sclerostin alone as a bone health indicator
This review builds on decades of bone research by consolidating what we know about sclerostin’s many roles. Previous studies identified sclerostin as important for bone regulation, but research was scattered across many journals and sometimes reached conflicting conclusions. By bringing this research together, the review shows that sclerostin is even more complex than initially thought. Earlier research focused on sclerostin’s role in bone formation, but newer studies reveal its effects on bone breakdown as well. The review also highlights that while sclerostin shows promise as a biomarker for bone health, it is less straightforward than initially hoped because so many factors influence it
The biggest limitation is that this is a review of existing research rather than a new study, so it is only as good as the studies it examines. Different studies may have used different methods to measure sclerostin, making comparisons difficult. The review notes that there is no standardized way to measure sclerostin across different laboratories, which means results from different tests may not be directly comparable. The authors acknowledge that vitamin D’s effects on sclerostin remain unclear, indicating gaps in current knowledge. The review also points out that while sclerostin levels correlate with bone mineral density, the relationship is not strong enough to use sclerostin as a standalone clinical tool. Finally, most research on sclerostin has been conducted in specific populations, so findings may not apply equally to all age groups, ethnic backgrounds, or health conditions
The Bottom Line
At this time, sclerostin measurement is primarily a research tool rather than a routine clinical test. If your doctor is concerned about bone health, established methods like bone density scans remain the standard approach. Maintaining bone health through regular weight-bearing exercise, adequate calcium and vitamin D intake, and managing kidney and metabolic health supports healthy sclerostin levels indirectly. As research continues and measurement methods become standardized, sclerostin testing may eventually become more clinically useful. Confidence level: Moderate. The evidence supports sclerostin’s importance in bone regulation, but clinical application requires further development
People with bone health concerns, those with kidney disease, individuals with metabolic disorders like diabetes, and anyone interested in understanding bone biology should find this information relevant. Older adults and postmenopausal women, who face higher osteoporosis risk, may eventually benefit from sclerostin testing once it becomes standardized. Healthcare providers specializing in bone health, endocrinology, and nephrology should be aware of sclerostin’s multiple influencing factors. People should not be concerned if they have not heard of sclerostin testing, as it is not yet a standard clinical tool for most patients
Changes in sclerostin levels can occur relatively quickly in response to factors like exercise or hormonal changes, potentially within weeks to months. However, meaningful changes in bone density from sclerostin-related factors typically take months to years to become apparent. Clinical applications of sclerostin testing are likely years away, pending standardization of measurement methods and larger clinical studies
Frequently Asked Questions
What is sclerostin and what does it do in your body?
Sclerostin is a protein that acts as a brake on bone formation. It slows down osteoblasts, the cells that build bone, while also affecting osteoclasts, the cells that break down bone. This dual role makes sclerostin a master regulator of bone balance and metabolism
Can a blood test for sclerostin tell me if my bones are healthy?
Not yet as a standalone test. While sclerostin levels show some association with bone mineral density, too many factors influence sclerostin for doctors to rely on it alone. Standardized measurement methods and more clinical research are needed before sclerostin testing becomes routine
How does exercise affect sclerostin levels?
Weight-bearing exercise and physical activity significantly reduce sclerostin levels. This makes biological sense because active people need less of the bone-building brake, allowing more bone formation to occur in response to the mechanical stress from exercise
Does vitamin D affect sclerostin levels?
The relationship between vitamin D and sclerostin remains controversial. Different studies reach different conclusions about whether vitamin D influences sclerostin levels, indicating this is an area where more research is needed to clarify the connection
Why do kidney problems affect sclerostin levels?
The kidneys help regulate sclerostin in the bloodstream, so kidney dysfunction can alter sclerostin levels. This is one reason why people with kidney disease often experience bone health problems and why kidney function is important for overall bone metabolism
Want to Apply This Research?
- Track weekly weight-bearing exercise minutes and correlate with any available sclerostin or bone health markers from medical tests. Record exercise type, duration, and intensity to identify patterns in bone-supporting activity
- Increase weight-bearing exercise to naturally lower sclerostin levels and support bone formation. Users can set weekly targets for activities like walking, jogging, strength training, or dancing, which mechanically load bones and trigger beneficial sclerostin changes
- Log kidney function test results, metabolic markers, and hormone levels when available from medical visits. Track these alongside exercise and dietary factors to identify personal patterns in factors that influence sclerostin and bone health over time
This article summarizes scientific research on sclerostin and bone metabolism for educational purposes. It is not medical advice and should not replace consultation with a qualified healthcare provider. Sclerostin testing is not currently a standard clinical tool for assessing bone health in most patients. If you have concerns about your bone health, osteoporosis risk, or kidney function, consult your doctor about appropriate screening and treatment options. Individual responses to factors affecting sclerostin vary based on age, health status, medications, and other conditions. Always discuss any new health concerns or changes in bone health with your healthcare provider before making decisions based on this information
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.